Prosigna® Breast Cancer Prognostic Gene Signature Assay
to Move Forward
Rapid IO Signature Development
IO 360™ GX Panel
Faster than qPCR. Simpler than NGS.
Expertly Curated. Ready to Use.
nCounter® Analysis Technology
More insights from
The nForm blog provides expert opinions on the latest hot topics in research from Neuroscience to spatial profiling and beyond!
Hear from the Experts
Register for one of our on-demand webinars to hear how customers are using nCounter Technology and also learn about new products in development.
on actionable answers
nFORM BLOG- PlexSet Reagents
Rethink how you want to quantify and analyze gene expression with nCounter® PlexSet™ Reagents. Our latest blog reviews three informational webinars from scientists comparing qPCR to PlexSet technology.
August 1, 2018
nFORM BLOG- Neuroscience
Five neuro grant program applicants were awarded nCounter Neuropathology or Neuroinflammation Panels. NanoString® followed up with each of the winners to explore how they intend to use the assays to advance their research.
July 18, 2018
Comprehensive analysis of microglia across neuropathological stages of Alzheimer’s disease (AD) - Sep 25, 2018 - 9:30am PST
Stefan Prokop, MD, University of Pennsylvania School of Medicine
Join this webinar to see how comprehensive analysis of microglia in different stages of AD in human brains using immunohistochemistry, cell type and pathway specific high-plex gene expression profiling, and morphology-driven high-plex protein expression profiling provides novel insight into the role of the immune system in AD pathogenesis and progression.
Take on the challenges of Autoimmunity research with the nCounter® Analysis System - aired July 18, 2018 - 9:00 a.m. (PST)
Kirsteen Maclean, PhD, Principal Field Application Scientist, NanoString
In this webinar, we discuss examples of leading research in the field of Autoimmunity that have utilized the nCounter® Analysis System to address important challenges including the development of gene signatures for early diagnosis, responder-non-responder profiling and treatment-induced autoimmunity.